We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

    • Cell signaling

    Health

    Breakthrough in Acute Leukaemia Treatment

    Recent research published in Nature reveals a potential breakthrough in acute leukaemia treatment, focusing on the role of PI3Kγ in cancer cells. The study identifies a dependency on the PI3Kγ complex in high-risk acute leukaemias, with promising results from treatment with a selective PI3Kγ inhibitor eganelisib. Combining eganelisib with cytarabine shows improved survival rates, offering hope for patients with acute leukaemia.

    Posted on Jhon
    Tech/Science

    Protein structures signal fresh targets for anticancer drugs

    Protein structures signal fresh targets for anticancer drugs Cell replication in our bodies is triggered by a cascade of molecular signals transmitted between proteins. Compounds that block these signals when they run amok show potential as cancer drugs. Scientists have…

    Posted on Jhon
    Health

    Study Reveals Need for Personalized Approach in Treating Allergy and Inflammatory Disorders

    A new study published in the Jan. 4, 2024, print issue of Cell sheds light on the tissue-specific actions of JAK1, revealing a potential need for a more nuanced therapeutic approach in treating allergy and inflammatory disorders. Conducted by researchers…

    Posted on Jhon